There might be a weight loss drug competitor to Ozempic


Zealand Pharma stock was soaring more than 34% on Monday, after the company announced strong results in a clinical trial for a liver disease drug that is also being tested for weight loss.
The news was welcomed by investors who are looking for the next blockbuster weight loss drug that could compete with the market’s current leaders, Novo Nordisk and Eli Lilly.

This story from was posted on 2024-02-27 by @aurorawave.


The Entire Business World on a Single Page. Free to Use →